P-197 Impact of local treatments on survival of patients with liver metastases from colorectal cancer (CRC) in real-life setting

Abstract

Liver is the most common site of metastases from CRC. Up to 70% of CRC patients develop liver metastases in their course of disease. Surgical resection is the only treatment that offers a chance of long-term survival, however, only a minority of patients is suitable for upfront surgery. Local therapies (including hybrid therapy approach) can be used to attain hepatic disease control in unresectable patients and possibly affect overall prognosis.